None listed
Conditions
Brief summary
This study aims to determine whether using wearable technology activity monitors coupled with brief behavioural counselling and goal setting can increase physical activity and decrease sitting time amongst breast cancer survivors. Who is it for? You may be eligible to join this study if you are a post-menopausal breast cancer survivor who was diagnosed with stage I-III breast cancer, and who has completed primary treatment (ongoing hormone therapy is acceptable). Eligible participants will also engage in less than 75 minutes of moderate-vigorous physical activity per week, more than six hours of sitting each day. Study details Participants in this study will be randomly allocated (by chance) to one of two groups. Participants in one group receive a novel 12 week intervention which involves: 1) Attending an initial information and training session; 2) wearing a technology activity monitor daily to enable real-time monitoring of physical activity and sitting time; and 3) receiving five behavioural counselling and goal setting sessions via telephone. The intervention will be followed by a 12 week maintenance period. Participants in the other group will receive no intervention for the first 12 weeks. After this time they will attend an information and training session and wear the activity monitor for 12 weeks. They will not receive the behavioural counselling and goal setting sessions. All participants will complete assessments by wearing an accelerometer and inclinometer at baseline, after 12 weeks, and after 24 weeks in order to evaluate physical activity and sitting time. The proposed intervention has the potential to be an inexpensive and sustainable addition to usual care provided by clinicians, allied health professionals or via telephone-delivered cancer information and support services (such as those delivered by Cancer Councils across Australia).
Interventions
- change of Study Coordinator (intervention now delivered by health coaches - staff with public health qualifications)
- physical function and cognitive function testing not administered
Sponsors
Cancer Council Victoria
Study design
Allocation
Randomised controlled trial
Intervention model
Other
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Post-menopausal breast cancer survivors, diagnosed with stage I-III breast cancer, who have completed primary treatment (surgery, chemotherapy, radiation therapy – ongoing hormone therapy is acceptable). Other eligibility criteria include: engaging in more than six hours of sitting each day; less than 75 minutes of moderate-vigorous physical activity per week; able to speak/write fluently in English; having daily access to a smart phone, mobile device or personal computer.
Exclusion criteria
Pre-menopausal women. Women diagnosed with breast cancer still undergoing primary treatment. Those engaging in less than six hours of sitting each day; more than 75 minutes of moderate-vigorous physical activity per week.
Outcome results
None listed